STARVIX

STARVIX specializes in advanced umbilical tissue products for medical applications, focusing on wound management and surgical sites. Their offerings include lyopreserved and cryopreserved umbilical tissue products, which are structural placental allografts derived from human umbilical cord tissue. These products retain essential components like placental cells, growth factors, and a hyaluronic acid-rich extracellular matrix, supporting effective wound healing and tissue repair. The company's products are designed for single-patient use and are versatile enough to conform to complex anatomical structures. They are suitable for treating a variety of acute and chronic wounds, including diabetic foot ulcers, venous leg ulcers, and surgical wounds. STARVIX products serve as wound covers, surgical barriers, or wraps, improving closure rates and providing a durable, biologically active matrix to enhance healing in high-risk patients across multiple surgical specialties.

• Employees 9